chr3-184352474-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_004366.6(CLCN2):​c.2240G>A​(p.Arg747His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000219 in 1,613,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00079 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00016 ( 0 hom. )

Consequence

CLCN2
NM_004366.6 missense

Scores

6
13

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts U:1B:2O:1

Conservation

PhyloP100: 1.86

Publications

5 publications found
Variant links:
Genes affected
CLCN2 (HGNC:2020): (chloride voltage-gated channel 2) This gene encodes a voltage-gated chloride channel. The encoded protein is a transmembrane protein that maintains chloride ion homeostasis in various cells. Defects in this gene may be a cause of certain epilepsies. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2012]
CLCN2 Gene-Disease associations (from GenCC):
  • leukoencephalopathy with mild cerebellar ataxia and white matter edema
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • epilepsy, idiopathic generalized, susceptibility to, 11
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • familial hyperaldosteronism type II
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010873437).
BP6
Variant 3-184352474-C-T is Benign according to our data. Variant chr3-184352474-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 217780.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000795 (121/152276) while in subpopulation AFR AF = 0.00253 (105/41562). AF 95% confidence interval is 0.00213. There are 0 homozygotes in GnomAd4. There are 49 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLCN2NM_004366.6 linkc.2240G>A p.Arg747His missense_variant Exon 20 of 24 ENST00000265593.9 NP_004357.3 P51788-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLCN2ENST00000265593.9 linkc.2240G>A p.Arg747His missense_variant Exon 20 of 24 1 NM_004366.6 ENSP00000265593.4 P51788-1

Frequencies

GnomAD3 genomes
AF:
0.000776
AC:
118
AN:
152158
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00246
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.000316
AC:
79
AN:
249940
AF XY:
0.000310
show subpopulations
Gnomad AFR exome
AF:
0.00186
Gnomad AMR exome
AF:
0.000464
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000142
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000159
AC:
233
AN:
1460900
Hom.:
0
Cov.:
33
AF XY:
0.000172
AC XY:
125
AN XY:
726726
show subpopulations
African (AFR)
AF:
0.00209
AC:
70
AN:
33480
American (AMR)
AF:
0.000515
AC:
23
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000557
AC:
48
AN:
86162
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52780
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000594
AC:
66
AN:
1111844
Other (OTH)
AF:
0.000364
AC:
22
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
15
29
44
58
73
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000795
AC:
121
AN:
152276
Hom.:
0
Cov.:
32
AF XY:
0.000658
AC XY:
49
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.00253
AC:
105
AN:
41562
American (AMR)
AF:
0.000327
AC:
5
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68028
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000359
Hom.:
0
Bravo
AF:
0.000952
ESP6500AA
AF:
0.00295
AC:
13
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000329
AC:
40
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.000416

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:1Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual disability Uncertain:1
Jan 01, 2019
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Leukoencephalopathy with mild cerebellar ataxia and white matter edema Other:1
-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.12
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.18
T;.;.;.
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.083
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.89
D;D;D;D
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.011
T;T;T;T
MetaSVM
Uncertain
-0.18
T
MutationAssessor
Benign
1.0
L;.;.;L
PhyloP100
1.9
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-1.6
N;N;N;N
REVEL
Benign
0.28
Sift
Benign
0.12
T;T;T;T
Sift4G
Benign
0.15
T;T;T;T
Polyphen
0.0020
B;B;.;.
Vest4
0.26
MVP
0.91
MPC
0.36
ClinPred
0.016
T
GERP RS
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.10
gMVP
0.47
Mutation Taster
=74/26
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144164281; hg19: chr3-184070262; API